Patent Assignment
Reel/Frame 057933/0603
Assignment of Assignor's Interest
Recorded: 2021-10-27
Pages: 12
Assignor
CARSGEN THERAPEUTICS CO., LTD.
Executed: 2021-01-22
Assignee
CAFA THERAPEUTICS LIMITED
2/3 EXCHANGE PLACE, IFSC, DUBLIN, D01 AE27, IRELAND
Covered Property
(1)
Tumor-Specific Anti-Egfr Antibody and Application Thereof
Application:
17/182,956 →
Publication:
US 2022/0017625
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 27, 2021
From: WANG, HUAMAO; SONG, BO
To: SHANGHAI YIJIE BIOTECHNOLOGY CO. LTD
Reel/Frame 057930/0118 →
Assignment of Assignor's Interest
Oct 27, 2021
From: SHANGHAI YIJIE BIOTECHNOLOGY CO. LTD
To: CARSGEN THERAPEUTICS CO., LTD.
Reel/Frame 057931/0333 →
Assignment of Assignor's Interest
Jun 15, 2022
From: CAFA THERAPEUTICS LIMITED
To: CRAGE MEDICAL CO., LIMITED
Reel/Frame 060208/0935 →